Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sheila R. Shulman"'
Autor:
Sheila R. Shulman, Louis Lasagna
Publikováno v:
Journal of Pharmaceutical Marketing & Management. 12:1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28a7881d210d3d4d24b7735d5d445fad
https://doi.org/10.3109/j058v12n02_01
https://doi.org/10.3109/j058v12n02_01
Autor:
Sheila R. Shulman, Michael Manocchia
Publikováno v:
PharmacoEconomics. 12:312-326
The Orphan Drug Act has become a staple of food and drug law in the US. The experience with the US programme continues to serve as a useful reference point as interest in orphan drug incentive programmes expands globally. This article first reviews d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b97a13060b2e54e0fc6247663366f21
https://doi.org/10.2165/00019053-199712030-00004
https://doi.org/10.2165/00019053-199712030-00004
Autor:
Sheila R. Shulman, Kenneth I. Kaitin
Publikováno v:
PharmacoEconomics. 9:121-133
The Prescription Drug User Fee Act of 1992 authorises the US Food and Drug Administration (FDA) to collect in excess of $US332 million in user fee revenues over a 5-year period. Not only did Congress determine that the revenues would be dedicated to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f591d26418cde8a0bf3e58dff91cdcc
https://doi.org/10.2165/00019053-199609020-00004
https://doi.org/10.2165/00019053-199609020-00004
Autor:
Sheila R. Shulman
Publikováno v:
PharmacoEconomics. 6:71-79
The influence of the Patented Medicine Prices Review Board in restraining the prices of patented drugs has been established over the past 6 years. Recent legislative and policy changes now in place may result in the Board assuming a more influential,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d2799ed4b5f0736e3e239e8132998c
https://doi.org/10.2165/00019053-199400061-00017
https://doi.org/10.2165/00019053-199400061-00017
Autor:
Sheila R. Shulman
Publikováno v:
PharmacoEconomics. 1:21-27
The delivery of health care services in the United States is increasingly influenced by the coverage determinations of third-party payers. This paper reviews 3 specific initiatives recently undertaken by the federal government that relate directly or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc696c40eca1ae0c1fc683c99c7f24f
https://doi.org/10.2165/00019053-199200011-00007
https://doi.org/10.2165/00019053-199200011-00007
Publikováno v:
Drug Information Journal. 26:41-52
To generate descriptive data about the process of therapeutic substitution, a survey was conducted in 10 hospitals in the Boston area. Interviews were conducted with 10 Pharmacy and Therapeutics (P...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2bd86ac7b62c98ff1d628fffb89a24b
https://doi.org/10.1177/009286159202600105
https://doi.org/10.1177/009286159202600105
Autor:
Sheila R. Shulman
Publikováno v:
Drug Information Journal. 32:363-365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b34adc7d7d860e0eec790ec9ffd99bae
https://doi.org/10.1177/009286159803200205
https://doi.org/10.1177/009286159803200205
Autor:
Sheila R. Shulman, Drusilla S. Raiford
Publikováno v:
The Journal of Clinical Pharmacology. 30:585-587
On june 22, 1987 regulations issued by the Food and Drug Administration in the United States codified procedures for the treatment use and sale of investigational new drugs outside of the clinical trial setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9419cf91d225ba23da5fe8e4517483
https://doi.org/10.1002/j.1552-4604.1990.tb01860.x
https://doi.org/10.1002/j.1552-4604.1990.tb01860.x
Autor:
Sheila R. Shulman
Publikováno v:
PharmacoEconomics. 14
Over the past decade, pharmaceutical benefit management companies (PBMs) have assumed an expanded role as intermediaries in the design and administration of pharmacy programmes. PBMs now provide a range of sophisticated, clinically oriented services
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c1d164a8d0c64f650a2f00323e9d50
https://pubmed.ncbi.nlm.nih.gov/10186482
https://pubmed.ncbi.nlm.nih.gov/10186482